VIVIAN VU: Open Payments
NPI 1790131183 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 7 payments from 6 companies in 2025. Trend: 2023 $484 · 2024 $175 · 2025 $363
Food & beverage: $263Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 1 | $127 |
| Astellas Pharma US Inc | 1 | $100 |
| Genentech USA, Inc. | 2 | $50 |
| PFIZER INC. | 1 | $38 |
| Melinta Therapeutics, LLC | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
Products named: Vanflyta, Venclexta, TIVDAK, Rezzayo, LIBTAYO.
Industry payments across CA — which companies pay providers there.
